INVIVO THERAPEUTICS HOLDINGS CORP. Insider Trading for March 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in INVIVO THERAPEUTICS HOLDINGS CORP..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in INVIVO THERAPEUTICS HOLDINGS CORP. for March 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 28 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.76 | 12,500 | 22,000 | 9,398,920 | 9.4 M to 9.4 M (-0.13 %) |
Mar 28 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.75 | 12,500 | 21,875 | 9,411,420 | 9.4 M to 9.4 M (-0.13 %) |
Mar 26 2014 | NVIV | INVIVO THERAPEUTIC ... | Ulich Thomas R | Chief Scientific Of ... | Option Exercise | A | 2.33 | 350,000 | 815,500 | 350,000 | |
Mar 26 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.71 | 12,500 | 21,375 | 9,423,920 | 9.4 M to 9.4 M (-0.13 %) |
Mar 26 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.78 | 12,500 | 22,250 | 9,436,420 | 9.4 M to 9.4 M (-0.13 %) |
Mar 26 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.85 | 22,900 | 42,365 | 9,448,920 | 9.5 M to 9.4 M (-0.24 %) |
Mar 26 2014 | NVIV | INVIVO THERAPEUTIC ... | JOSEPH TAMARA L | SVP, General Counse ... | Option Exercise | A | 1.88 | 300,000 | 564,000 | 300,000 | |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.48 | 12,500 | 31,000 | 9,661,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.47 | 12,500 | 30,875 | 9,673,920 | 9.7 M to 9.7 M (-0.13 %) |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.37 | 12,500 | 29,625 | 9,686,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.48 | 12,500 | 31,000 | 9,661,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.47 | 12,500 | 30,875 | 9,673,920 | 9.7 M to 9.7 M (-0.13 %) |
Mar 17 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.37 | 12,500 | 29,625 | 9,686,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 1.95 | 2,100 | 4,095 | 9,621,820 | 9.6 M to 9.6 M (-0.02 %) |
Mar 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.01 | 12,500 | 25,125 | 9,623,920 | 9.6 M to 9.6 M (-0.13 %) |
Mar 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.19 | 12,500 | 27,375 | 9,636,420 | 9.6 M to 9.6 M (-0.13 %) |
Mar 21 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.29 | 12,500 | 28,625 | 9,648,920 | 9.7 M to 9.6 M (-0.13 %) |
Mar 12 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.30 | 12,500 | 28,750 | 9,698,920 | 9.7 M to 9.7 M (-0.13 %) |
Mar 12 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.31 | 12,500 | 28,875 | 9,711,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 12 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.37 | 12,500 | 29,625 | 9,723,920 | 9.7 M to 9.7 M (-0.13 %) |
Mar 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.43 | 12,500 | 30,375 | 9,736,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.45 | 12,500 | 30,625 | 9,748,920 | 9.8 M to 9.7 M (-0.13 %) |
Mar 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.43 | 12,500 | 30,375 | 9,736,420 | 9.7 M to 9.7 M (-0.13 %) |
Mar 10 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.45 | 12,500 | 30,625 | 9,748,920 | 9.8 M to 9.7 M (-0.13 %) |
Mar 05 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.44 | 12,500 | 30,500 | 9,748,920 | 9.8 M to 9.7 M (-0.13 %) |
Mar 05 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.52 | 12,500 | 31,500 | 9,761,420 | 9.8 M to 9.8 M (-0.13 %) |
Mar 05 2014 | NVIV | INVIVO THERAPEUTIC ... | REYNOLDS FRANCIS | 10% Owner | Sell | S | 2.52 | 12,500 | 31,500 | 9,773,920 | 9.8 M to 9.8 M (-0.13 %) |